How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
Imaging of HER2-positive Cancer With Site-Specifically Labeled 89Zr-ss-Pertuzumab
Description:
The purpose of this study is to see whether 89Zr-ss-pertuzumab is safe in people with HER2+ cancer.
Sponsor:
Memorial Sloan Kettering Cancer Center
Government Study Link:
NCT04692831 - Click here to see study onClinicalTrials.gov
